Gaming
 

Oxcarbazepine

From the Halo Fan Fiction Wikia, writing 12,596 fan fiction articles

This article, Oxcarbazepine, was written by RelentlessRecusant. Please do not edit this fiction without the writer's permission.

Oxcarbazepine (OCZ)
Chemical information
IUPAC Nomenclature

10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Chemical Formula

C15H12N2O2

Molecular Weight

252.27 g/mol

Clinical information
Clinical Usage
  • Anticonvulsant
  • Neuropathic pain
  • Mood stabilizer
Mechanism of Action

Inhibition of central nervous fast sodium (Na+) current

Route of Administration

Oral

Pharmacokinetic information
Metabolism

Hepatic metabolism

Elimination Half-Life

Moderately low

  [Source]

Oxcarbazepine (OCZ), IUPAC name 10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide, is a small-molecule chemical modulator of central nervous sodium (Na+) channels[1], likely Nav1.1 (SCN1A) and Nav1.2 (SCN2A) and is an inhibitor of the fast Na+ conductance current (INaF). It is an oxidated heterocyclic derivative of carbamazepine, a carbamoyl derivative of iminodibenzyls.[2]

It is marketed primarily as an anti-epileptic drug (AED) because of its neuromodulatory effects on the central fast Na+ current, although oxcarbazepine has a broad activity against other non-epileptic central neurological pathologies, including neuropathic pain, trigeminal neuralgia, maniac effective bipolar disorder, and alcohol withdrawal.[2]

Oxcarbazepine's activity is mediated by its main human metabolite; monohydroxy metabolite (MHD).[3]

[edit] References

  1. Rogawski and Löscher (2004). The Neurobiology of Antiepileptic Drugs. Nature Reviews Neuroscience (5): 553-564.
  2. 2.0 2.1 Rogawski and Löscher (2004). The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nature Medicine (10): 685-692.
  3. Schmutz et. al (1991). Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action. Epilepsia (35): S47-50.


Chemical Biology: Small-Molecule Control of Biological Systems (RelentlessRecusant)
Biological Targets
Compound Names
Receptor Tyrosine Kinases A-83-01 (TGFβ/Activin) · BPIQ-II (EGFR) · Dorsomorphin/LDN-193189 (TGFβ/BMP) · SU5402 (FGFR)
Signaling Kinases A-769662 (AMPK) · BMS-354825 (BCR-ABL, Src)· BIO-Acetoxime (GSK3) · CHIR99021 (GSK3) · GO 6976 (PKC) · IMD-0354 (IκBa) · PD184352 (MAPK) · SB203580 (MAPK) · Y-27632 (ROCK)
G Protein-Coupled Receptor (+)-WIN-55212 (CB1/CB2) · ±-Sulpride (D2) · A 841720 (mGluR1) · BP-554 (5-HT1A) · Hh-Ag1.5 (Smo) · Cyclopamine/KAAD-Cyclopamine (Smo) · SANT1 (Smo) · SB-277011 (D3)
Ion Channels BAY K8644 (Cav1.2) · Bicuculline (GABAAR) · Cymarin (Na+/H+) · G-strophanthin (Na+/H+) · L-AP4 (Na+/H+) · Oxcarbazepine (Na+) · Resiniferatoxin (TRPV1) · Sarmentogenin (Na+/H+) · Theanine (AMPAR, NMDAR)
Transporters O-1783 (DAT) · WF-23 (DAT, SERT)
Nuclear Receptor All-trans retinoic acid (RAR/RXR) · GW501516 (PPARδ) · RU-486 (Nr3c1, Nr3c3)
Protein Phosphatases Endothall (PP2A)
Polypharmacological Phosphoserine (mGluR4) · PK115-584 (Tcf4/β-catenin, PKC) · Pluripotin · Reversine
Other 2C-E (DAT) · 4-methoxyphenyl-HTI-286 (α/β-tubulin) · Compound E/DAPT (presenilin-1) · D-cysteine · D-phenylalanine · Flurbiprofen (COX) · JZL184 (MAGL) · QS11 (RAFGAP1) · RO-28-1675 (glucokinase) · Robotnikinin (Shh) · Selegiline (MAOB)
Uncharacterized Neuropathiazol
Libraries Kinase Inhibitor Library
Publications
Small molecule-mediated manipulation of the adult human induces selective and reversible control of physiological and psychological phenotype (Rubin et. al, 2590. Nature Medicine)
Source · Edit